×
ADVERTISEMENT
ADVERTISEMENT

European body's opinion takes Dr Reddy’s biosimilar cancer drug closer to launch in EU countries

Dr Reddy’s had previously received the EU GMP certificate for its Rituximab drug substance and drug product manufacturing facility located in Hyderabad.
Last Updated : 29 July 2024, 10:53 IST
ADVERTISEMENT

Follow Us :

Comments
ADVERTISEMENT
Published 29 July 2024, 10:53 IST

Follow us on :

Follow Us